Curis Inc (CRIS) stock analysis and AI prediction
The company facts of Curis Inc, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Curis Inc
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $4.5 million
- Size
- Micro cap
- Employees
- 24
- Headquarters
- LEXINGTON, MA
- Listed since
- Aug. 1, 2000
- Website
- curis.com
More Healthcare stocks
Other micro cap stocks
Keep going
CRIS questions
What is the AI prediction for CRIS stock?
Each market day our model rates Curis Inc (CRIS) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the CRIS prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for CRIS?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see CRIS options?
The CRIS options page explains its calls, puts and Greeks. The full CRIS options chain, every strike and expiry, is in the OpPreds app.